|
Delayed
Nasdaq
16:00:00 2026-09-04 EDT
|
5-day change | 1st Jan Change | ||
| 63.96 USD | +0.13% |
|
+5.11% | +65.53% |
| 09-04 | Royalty Pharma Announces Update on Novartis Phase 3 Topline Results for Pelacarsen | CI |
| 09-02 | Teva's immune disorder drug meets main goal in mid-stage trial | RE |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| RPRX | Delayed | |
CBOE
| RPRX | Real-time | |
|
Mexican S.E.
| RPRX N | End-of-day quote | |
|
Boerse Muenchen
| RPD | Real-time | |
|
Tradegate
| RPD | Real-time | |
|
Deutsche Boerse AG
| RPD | Delayed | |
|
Börse Stuttgart
| RPD | Delayed | |
|
Xetra
| RPD | Delayed |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Bullish |
| Resistance | 64.33 | 70.37 | 76.69 |
| Spread/Res. | -0.57% | -9.10% | -16.60% |
| Spread/Supp. | +5.11% | +14.89% | +33.53% |
| Support | 60.85 | 55.67 | 47.9 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- RPRX Stock
- Charts Royalty Pharma plc
Select your edition
All financial news and data tailored to specific country editions
